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Abstract 
This study investigated the effects of oral taurine supplementation on cycling time to 
exhaustion at a fixed-intensity and thermoregulation in the heat. In a double-blind, randomised 
crossover design, 11 healthy males participated in a time to exhaustion test in the heat (35 °C, 
40% RH), cycling at the power output associated with ventilatory threshold, 2-h after ingesting: 
Taurine (50 mg·kg-1) or placebo (3 mg·kg-1 maltodextrin). Core and mean skin temperature, 
mean sweat rate, heart rate, rating of perceived exertion (RPE), thermal comfort and thermal 
sensation were measured during exercise and blood lactate concentration (B[La]) was measured 
after exercise. Taurine supplementation increased time to exhaustion by 10% (25.16 min vs. 
22.43 min, p = 0.040), end sweat rate by 12.7% (687 nL∙min-1 vs. 600 nL∙min-1, p = 0.034) and 
decreased B[La] by 16.5% (5.75 mmol∙L-1 vs. 6.85 mmol∙L-1, p = 0.033). Core temperature was 
lower in the final 10% of the time to exhaustion (38.5 °C vs. 38.1 °C, p = 0.049). Taurine 
supplementation increased time to exhaustion and local sweating, while decreasing RPE and 
core temperature in the later stages of exercise, as well as reducing post-exercise B[La]. This 
study provides evidence of taurine’s role in thermoregulatory processes. These findings have 
implications for the short-term preparation strategies of individuals exercising in the heat. 
Based on these findings, a single dose of taurine 2-h prior to training or competition would 
provide an ergogenic and thermoregulatory effect.  
 
Keywords amino acids; sweating; cooling; ergogenic aids.  
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Introduction  
 
Taurine, a sulphur containing amino acid, is abundantly expressed in mammalian tissue, 
accounting for 50–60% of the free amino acid pool (Huxtable, 1992). In human skeletal 
muscle, taurine concentration is approximately four times higher in type I compared to type II 
fibres (Harris, Dunnett & Greenhaff, 1998). Taurine is widely reported to facilitate a number of 
biological processes, such as sarcoplasmic reticulum Ca2+ handling in both type I and II fibres 
(Hamilton, Berg, Easton & Bakker, 2006; Dutka, Lamboley, Murphy & Lamb, 2014) and 
regulation of cell fluid volume (Cuisinier et al., 2002). Perhaps less well known are the anti-
oxidative properties of taurine, elicited though a mitochondrial buffering action (Hansen, 
Andersen, Birkedal, Cornett & Wibrand, 2006; Hansen, Andersen, Cornett, Gradinaru & 
Grunnet,  2010), as well as its capacity to act as a neuromodulator, with a suggested influence 
on the thermoregulatory control centres in animal models (Frosini et al., 2000).  
 
There is a lack of consensus regarding taurine’s mechanisms of ergogenic action in humans, yet 
this semi-essential amino-acid (Huxtable, 1992) is responsible for improvements in endurance 
performance (Zhang, Izumi, Kagamimori, Sokejima, & Yamagami, 2004; Balshaw, 
Bampouras, Barry & Sparks, 2012; Ahmadian, Roshan & Ashourpore, 2017; Warnock, 
Jeffries, Patterson & Waldron, 2017; Waldron, Knight, Tallent, Patterson & Jeffries, 2018a) 
and is actively carried into most major organs via taurine transporters (TauT) (Ito et al., 2010). 
While oral taurine supplementation may not increase resting muscle content, increased plasma 
taurine levels following oral supplementation (Galloway, Talanian, Shoveller, Heigenhauser & 
Spriet, 2008) are likely to hinder its normal extrusion from skeletal cells (thus supressing 
intracellular release) as part of an osmoregulatory function during exercise (Cuisinier et al., 
2002). Therefore, it is feasible that a combination of mechanisms explain the recent meta-
analytic findings, demonstrating taurine’s ergogenic effect on endurance performance in 
humans (Waldron, Patterson, Tallent, & Jeffries, 2018b). 
 
Thermal strain is exacerbated by a combination of prolonged exercise and high environmental 
temperatures or humidity, which can cause a continuous rise in core temperature beyond 
homeostatic ranges (Nybo, 2008). The net effects of thermal strain are characterised by the heat 
balance equation, where heat energy is gained or dissipated via evaporation, conduction, 
convection and radiation (Gagge & Gonzalez, 1996). In thermally-strained humans, heat is 
4 
 
chiefly dissipated via evaporative and convective processes, as governed by the 
thermoregulatory centre in the hypothalamus (Gagge & Gonzalez, 1996). Cutaneous 
vasodilation and sweating (among other processes) support these avenues of heat loss by 
attenuating the rate of rise in core temperature during exercise (Marino et al., 2000; Sawka, 
Leon, Montain & Sonna, 2011). In relation to the current study, smaller increases in core 
temperature have been observed in heat-stressed rabbits compared to thermoneutral controls 
after intrathecal infusion of taurine (Frosini et al., 2000). It is possible that oral ingestion, rather 
than central infusion, could elicit similar effects in humans. Furthermore, taurine has a number 
of peripheral actions, particularly as a vaso-relaxant (Sun et al., 2016), which could facilitate 
convective and evaporative cooling processes. Taurine’s inotropic effects on the heart (Satoh & 
Sperelakis, 1998) and possible influence on stroke volume (Baum & Weiß, 2001) might also 
offset the deleterious effects of heat stress on cardiac efficiency and subsequent endurance 
performance (Gonzalez-Alonso, 2012). However, none of these questions have been addressed 
in exercising, thermally-stressed humans.   
 
The purpose of this study was to investigate the effects of acute oral taurine supplementation on 
thermoregulation during cycling exercise of a fixed intensity in the heat (35 °C; 40% relative 
humidity). It was hypothesised that taurine would extend time to exhaustion in the heat and 
delay the rate of rise in core temperature by enhancing convective or evaporative cooling 
potential.    
 
Materials and methods 
Participants  
Eleven non-heat acclimated healthy males volunteered for this study (age 23 ± 2 years, stature 
180 ± 60 cm, body mass 83.0 ± 9.5 kg, maximal oxygen uptake (V̇O2max) 46.0 ± 6.3 ml·min-
1·kg-1, maximal aerobic power output 305 ± 29 W). Given the typical effect sizes (Cohen’s d = 
0.4) reported using taurine to improve endurance performance (Waldron et al., 2018b) in 
thermoneutral environments, G*Power (Version 3.0.10; Universität Düsseldorf, Germany) was 
used to calculate an a-priori sample size of 11, which was sufficient to identify differences 
between groups with a statistical power of 0.80. Participants were asked to refrain from alcohol 
and caffeine consumption for 24-h and avoid strenuous exercise for 48-h prior to testing. All 
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participants gave written informed consent. Ethical approval was provided by the institutional 
ethics committee, which was conducted in accordance with the 1964 Helsinki declaration. 
 
Design 
The study adopted a double-blind, randomised crossover design. All participants reported to the 
laboratory on three separate occasions, each separated by a maximum of 96-h and minimum 
72-h to minimise acclimation effects. The first visit comprised preliminary testing and 
familiarisation. On visits two and three, the participants completed the experimental trials, 
where they ingested taurine or placebo 2-h before exercise. Randomisation was conducted by 
generating random numbers for all participants, across each condition using online software. 
Each laboratory visit was conducted at the same time of day.  
 
Preliminary testing 
During visit one, participants undertook an incremental exercise test to volitional exhaustion on 
a mechanically-braked cycle ergometer (Monark Exercise AB, Ergomedic 874E, Varberg, 
Sweden) in thermoneutral conditions (19.2 ± 0.8 °C) to determine ?̇?𝑉O2max and the power output 
at ventilatory threshold. Participants cycled for 5-min at 80 W to warm-up and rested for 5-min 
before starting the test. The test started at a workload of 120 W and increased 24 W·min-1 at a 
fixed cadence of 80 rev·min-1 until volitional exhaustion or when cadence dropped below 70 
rev·min-1 for more than 10-s. Oxygen uptake (?̇?𝑉O2) was measured using breath-by-breath 
expired air analysis (Jaeger Vyntus CPX, Hoechberg, Germany). The gas analyser was 
calibrated before every trial with gases of known concentration (15.95% O2, 4.97% CO2, BAL. 
N2) and the turbine volume transducer was calibrated automatically by the system at flow 
values of 2 L·s-1 and 0.2 L·s-1. Heart rate (HR) was recorded throughout the trial (Polar Heart 
Rate Monitor M400, Warwick, UK). ?̇?𝑉O2max was calculated by measuring the highest 30-s 
average ?̇?𝑉O2 peak power was measured as the highest power output recorded during the test for 
a full minute. After 20-min of rest, participants conducted a familiarisation, comprising 
maximal constant load exercise at the power output associated with ventilatory threshold in an 
environmental chamber (Sporting Edge UK, Basingstoke, UK) set to experimental conditions 
(35 ± 0.3 °C, 40 ± 0.3 % RH). Breath-by-breath ?̇?𝑉O2 and ?̇?𝑉CO2 data from the incremental 
cycling test was used to plot ventilatory threshold, using the simplified v-slope method 
(Scheider, Phillips & Stoffolano, 1993). The mean power output at thermoneutral ventilatory 
threshold was 203 ± 23 W, which was fixed for all experimental trials. This threshold was 
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selected as it was deemed appropriate to evaluate endurance capacity at a repeatable, sub-
maximal fixed intensity, while increasing the rate of metabolic heat production sufficient to 
induce thermoregulatory responses.         
 
Experimental trials  
All subsequent tests were conducted in the heat (35 ± 0.3 °C, 40 ± 0.6 % RH). Upon arrival at 
the laboratory, 1-h prior to testing, participants were instructed to insert a rectal thermistor 
(Edale Instruments Ltd, Cambridge, UK) 10 cm past the anal sphincter to measure core 
temperature (Tcore). Tcore was recorded every 1-min via a scanning thermometer type CDS 1.0 
(Edale Instruments Ltd, Cambridge, UK). A urine sample was also provided to determine 
hydration status using a refractometer (Pocket Osmochek, Vitech Scientific Ltd, West Sussex, 
UK). A reading of  > 600 mOsm·kg-1·H2O-1 indicated the threshold of hypohydration, in which 
case the participant consumed 500 ml of water and waited 30-min before testing.  
 
The participants’ body mass was recorded wearing cycling shorts and rectal thermistor inserted. 
The participants were instructed to abstain from drinking fluids until the end of the test. Skin 
thermistors (Grant Instruments Ltd., Cambridge, UK) were then attached to four sites on the 
participants’ right side: upper chest, mid humerus, mid-calf and mid-thigh. Skin temperature 
was recorded continuously via a Squirrel data logger (SQ2010, Grant Instruments Ltd., 
Cambridge, UK) and reported every 1-min. Mean skin temperature (Tskin) was calculated using 
Ramanathan’s equation (Ramanathan, 1964): Tskin = 0.3 x (Tchest + Tarm) + 0.2 x (Tthigh + Tcalf). 
Prior to fitting skin thermistors, the skin was cleaned with soap and water and dry shaved, 
before being thoroughly dried. Local sweat rate was measured using a Q-Sweat system (WR 
Medical Electronics Co., Stillwater, MN). Ventilated capsules were fixed proximal to the skin 
thermistors on the right-side of the body. Dry air was continuously delivered through Teflon-
lined tygon tubing at a fixed flow rate of 60 sccm·min-1 between four separate sweat capsules 
mounted on the skin’s surface and the Q-sweat device. Fluid released from the sweat glands is 
transiently incorporated into the dry air, with the change in temperature and relative humidity 
monitored by the Q-Sweat device. The capsule size was 0.781 cm2. Sweat rate was calculated 
using standard vapour pressure equations and expressed in nL·min-1. Mean sweat rate was 
calculated by averaging the four sweat sites and reported every 1-min.  
 
Participants then entered the environmental chamber and completed a 3-min warm-up at 80 W, 
followed by 2-min of rest. Participants were instructed to maintain a pedal cadence of 80 
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rev·min-1 at an intensity equivalent to thermoneutral ventilatory threshold until complete 
exhaustion. Exhaustion was defined as voluntary withdrawal or when pedal cadence dropped 
below 70 rev·min-1 for more than 10-s. The coefficient of variation for this test in our 
laboratory is 3.8% while cycling in the heat. Ratings of perceived exertion (RPE) were 
recorded on a 6 to 20 point Borg scale. Thermal comfort (TC) was recorded on a 7-point scale 
where -3 = “much too cool”, 0 = “comfortable”, and 3 = “much too warm” (Bedford, 1936). 
Thermal sensation (TS) was recorded on a 9-point scale where -4 = “very cold”, 0 = “neutral”, 
and 4 = “very hot”. RPE, TC and TS were recorded every 3-min and at completion. One-min 
post exercise, a blood lactate sample was taken from the right ear lobe using a lancet and 
analysed by an automated analyser (Biosen C_Line, EKF diagnostic GmbH, Barleben, 
Germany). Skin thermistors and sweat capsules were also removed post-exercise, before being 
towel-dried and re-weighed to indicate fluid losses during exercise. 
 
Supplementation  
All supplements were prepared in powder form, which were measured using an analytical 
balance (Precisa 125A, Precisa Gravimetrics AG, Zurich, Switzerland) and ingested in a 
gelatine capsule. The capsules contained one of the following: taurine (T) (50 mg∙kg-1 BM) or a 
placebo (P) (maltodextrin) (3 mg∙kg-1 BM) and were administered to participants 2-h prior to 
exercise. The 2-h timing was chosen as it captures the likely range of peak plasma availability 
of taurine after oral administration (Galloway et al., 2008; Ghandforoush-Sattari, Mashayekhi, 
Krishna, Thompson & Routledge, 2010). Participants’ body mass was taken prior to each trial 
to measure the correct dose and the supplements were balanced such that an equal number of 
capsules were ingested between conditions. The taurine dosage followed published 
recommendations (Warnock et al. 2017; Waldron et al., 2018a). The supplements were sourced 
from the company (My Protein, Manchester, UK).  
 
Statistical analysis 
A two-way repeated measures analysis of variance (RM-ANOVA) was conducted, with 
condition (taurine or placebo) and time (10% epochs across the trials) as the independent 
variables. A Greenhouse-Geisser correction was applied when the assumption of sphericity was 
violated. Where interaction effects were found, post-hoc analysis was performed with 
Bonferroni tests to identify pairwise differences. Two-tailed paired samples t-test identified 
significant differences between the performance trials. A Wilcoxon Signed-Rank test was 
performed on non-parametric data across time points. Statistical significance was accepted at P 
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< 0.05 and all analyses were performed on IBM SPSS Statistics (Version 21, IBM Corp., 
Armonk, NY, USA). The magnitude of effect was calculated with partial eta-squared 
(ηp2) according to the following criteria: 0.02, a small difference; 0.13, a moderate difference; 
0.26 a large difference (Cohen, 1988). Cohen’s d was calculated to interpret the effect of 
pairwise changes. 
 
Results 
Time to exhaustion at the power output associated with ventilatory threshold in 35 °C/40% RH 
was increased by ~ 10% with nine out of the eleven participants extending their performance 
after taurine supplementation (Taurine = 25.16 ± 5.25 min; Placebo = 22.43 ± 4.28 min) (t(10) = 
2.353, p = 0.040, Cohen’s d = 0.70) (Figure 1). There were also no trial order effects of the 
time to exhaustion (P = 0.203). 
 
*** Insert Figure 1 here *** 
 
Core temperature increased with time (F(19,190) = 174.954 , p < 0.001, ηp2 = 0.946), with no 
main effect for condition (F(1,10) = 0.035 , p = 0.855, ηp2 = 0.004); however, there was a 
condition × time interaction  (F(19,190) = 3.715 , p < 0.001, ηp2 = 0.271). Pairwise analysis 
confirmed that core temperature was reduced in the taurine condition only at the 100% epoch 
(Placebo = 38.5 ± 0.4 °C; Taurine = 38.1 ± 0.4 °C) (t(10) = 2.241, p = 0.049) (Figure 2 A). 
Mean skin temperature increased with time in both conditions (F(19,190) = 77.692 , p < 0.001, ηp2 
= 0.886), without condition effects (F(1,10) = 1.235 , p = 0.293, ηp2 = 0.110) or an interaction 
with time (F(19,190) = 1.562, p = 0.069, ηp2 = 0.135) (Figure 2 C). 
 
*** Insert Figure 2 here *** 
 
Mean sweat rate increased with time in both conditions (F(19,190) = 51.921 , p < 0.001, ηp2 = 
0.839) and was increased in the taurine condition relative to placebo (F(1,10) = 23.218 , p = 
0.001, ηp2 = 0.699). There was also a large condition × time interaction effect (F(19,190) = 3.654, 
p < 0.001, ηp2 = 0.268) (Figure 3). Post-hoc analysis revealed that mean sweat rate was higher 
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at all stages beyond 20 % into the exercise test (p < 0.05). At the end of the exercise trial, mean 
local sweat rate was ~13% higher in the taurine condition (Taurine = 687 ± 144 nL·min-1; 
Placebo = 600 ± 194 nL·min-1) (t(10) = 9.624, p = 0.034). Pre-to-post changes in body mass 
were also increased ~ 42 % in the taurine condition (Taurine = 786 ± 232 g; Placebo = 455 ± 
281 g) (t(10) = 5.434, p = 0.024).  
 
*** Insert Figure 3 here *** 
 
Heart rate increased with time in both conditions (F(1.743,17.432) = 166.847, p < 0.001, ηp2 = 
0.943); however, there were no main effects for condition (F(1,10) = 0.410, p = 0.536, ηp2 = 
0.039), nor was there an interactions (F(1.706,17.062) = 0.512, p = 0.863, ηp2 = 0.049). A Wilcoxon 
Signed-Rank test indicated differences in RPE at 18-min (Taurine = 18 ± 1; Placebo = 19 ± 1; Z 
= -2.264, p = 0.024) and end exercise (Taurine = 19 ± 1; Placebo = 20 ± 1; Z = -2.449, p = 
0.014) (Figure 4 A). There were no differences between conditions for thermal comfort or 
thermal sensation (p > 0.05) (Figure 4 B&C).  
 
*** Insert Figure 4 here *** 
 
Post-test B[La] was reduced by 16.5% following taurine supplementation (Taurine = 5.75 ± 
2.15 mmol·L-1; Placebo = 6.85 ± 1.77 mmol·L-1) (t(10) = -2.470, p = 0.033). 
 
Discussion 
We investigated the effects of taurine supplementation on thermoregulation and time to 
exhaustion in the heat. The key findings were that time to exhaustion in the heat (35 °C) 
increased by ~ 10% and sweat rate by ~ 12.7% at end exercise following taurine 
supplementation. The 10% increase in time to exhaustion surpassed the CV% of 3.8%, thus 
denoting a true change in performance. Whilst there were no consistent differences in core 
and skin temperature between conditions during the earlier stages of the time to exhaustion, a 
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lower core temperature was found during the final 10% of the trial and there was a trend for 
‘small’ reductions in skin temperature based on effect sizes. Collectively, these 
thermoregulatory changes might partly explain the observed improvement in performance.  
 
There is growing evidence to support the efficacy of taurine as an ergogenic aid for exercise 
performance (Souza, Del Coso, Casonatto & Polito, 2016; Waldron et al., 2018b). These 
changes are commonly attributed to improved mechanical efficiency (Paulucio et al., 2017) or 
improved efficiency of ATP turnover in the muscle cell (Hansen et al., 2010). Here, we 
extend these observations to report an increase in performance of 10% in the heat (35 °C). 
This change was larger than the typical 2-6% increases in performance reported following 
oral taurine administration in thermoneutral environments (Zhang et al., 2004; Balshaw et al., 
2012; Waldron et al., 2018a). Given that taurine’s capacity to elicit changes in time to 
exhaustion is markedly larger in the heat, our findings naturally infer a role for taurine in 
thermoregulatory control processes.  
 
Endurance exercise in the heat ceases for number of physiological reasons (Tucker & Noakes, 
2009). For example, during exhaustive, fixed-resistance exercise in hot conditions, reductions 
in cycling power output have been reported, alongside declines in cardiac output and stroke 
volume, thus impairing muscle blood flow and oxygenation (Gonzalez-Alonso & Calbet, 
2003). Taurine has a well-established inotropic action on cardiac muscle fibre (Satoh & 
Sperelakis, 1998) and has been shown to increase stroke volume when consumed as part of an 
energy drink (Baum & Weis, 2001). Given the established effects of taurine on cardiac 
myocytes, this might have been anticipated to offset fatigue-induced reductions in cardiac 
efficiency during performance. However, there were no changes in heart rate, which are likely 
to have been lower in the taurine condition if this mechanism were to explain the change in 
performance. As such, the increased performance and delayed fatigue in the taurine condition 
most likely occurred for different reasons.  
 
The changes observed in local sweat rate, total body fluid losses and core temperature were 
remarkable and highlight, for the first time, a significant role for taurine in human 
thermoregulation. Sweat response from eccrine glands is governed by the thermoregulatory 
centre in the hypothalamus, which directs the sympathetic nervous system to increase sweat 
secretion (Shibasaki & Crandall, 2010). These changes in sweat response occurred from the 
early stages of the exercise bout, prior to excessive exercise or external thermal stimulus, and 
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appear to have influenced skin temperature, which was also lower in the taurine condition. 
Core temperature is the net result of heat gain and dissipation, with sweating contributing > 
70% to heat loss during exercise in hot conditions (Marino et al., 2000). Thus, 
thermoregulation is increasingly dependent upon evaporative cooling as an avenue of heat 
loss during exercise. Taurine ingestion appears to augment the local sweating responses, such 
that the rate of rise in core temperature at the later stages of the trial was reduced compared to 
placebo, culminating in a lower core temperature at the end-point of the trial. The cooler skin 
temperature also generates a greater core-shell gradient, thus facilitating convective heat loss. 
The increased thermal stress observed during the placebo condition is most likely responsible 
for the earlier cessation of exercise. Indeed, hyperthermia may cause sub-conscious 
anticipatory reductions in skeletal muscle recruitment and subsequent force production of the 
lower limbs prior to the attainment of the hypothesised ‘critical’ (~ 40 °C) core temperature 
(Tucker, Rauch, Harley & Noakes, 2004). Others have reported relationships (r2 = 0.98) 
between core temperature and electroencephalographic 𝛼𝛼 − 𝑡𝑡𝑡𝑡 − 𝛽𝛽  wave ratios, which 
indicate supressed arousal levels and can be used to infer a reduction in central drive (Nielsen, 
Hyldig, Bidstrup, Gonzales-Alonso & Cristoffersen, 2001). Therefore, hyperthermic fatigue is 
mostly commonly ascribed to centrally-acting mechanisms (Nybo, 2008). 
 
Taurine acts as a neuromodulator in various brain areas and is a GABAA receptor agonist (Jia 
et al., 2008). Heat stress induces the release of both GABA and taurine from the 
hypothalamus into the cerebrospinal fluid (CSF), indicating their activity in response to 
temperature changes in the domain of thermoregulatory control (Frosini et al., 2000). 
Similarly, patients with heat stroke, who exhibit an array of neurological disorders, 
demonstrate increases in urinary taurine concentrations following cellular release, that are 
subsequently reduced following recovery from hyperthermic states (Bouchama, El-Yazigi, 
Yusuf & Al-Sediary, 1993). Whilst we did not intend to directly measure central mechanisms 
in this study, the marked increase in autonomic sudomotor responses demonstrated across 
most stages of the trials in the taurine condition strongly infers a change in the centrally-
mediated thermoregulatory set-point. More specifically, we postulate that the resulting 
increase in the onset and volume of sweating in the taurine condition was sufficient to delay 
the progression of core temperature, thus delaying hyperthermic fatigue and extending time to 
exhaustion. Interestingly, plasma taurine can readily cross the blood-brain barrier via a TauT 
(Kang, 2000) and infiltrate hypothalamic regions of the brain, albeit more slowly than central 
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infusions. The accumulation of taurine in these central locations presumably reduces core 
temperature via taurine binding sites or antagonism of GABA receptors, which are established 
effectors of hypothermia via distinct neural pathways (Quéva et al., 2003; Frosini et al., 
2003). Higher plasma availability following oral ingestion is likely to drive the transport of 
taurine across the blood-brain barrier into these central areas, where it can interact with target 
receptors and instigate thermoregulatory responses, such as increasing sudomotor function. 
The changes found in local sweating and core temperature in the taurine condition have 
implications beyond sports and exercise, which could include the application to occupations 
requiring routine heat exposure, such as the emergency or military services. Supplements that 
augment the sweating response could also be useful to counteract milder forms of 
hyperhidrosis. Further work is needed to corroborate these findings and investigate the 
application to other populations.      
 
Owing to its molecular structure, taurine is an endogenously free sulfonic acid and acts to 
control the movement of fluids via osmosis (Cuisinier et al., 2002). Indeed, it is this function 
that explains its extrusion from intra-cellular compartments during exercise, where it is 
transported into the extra-cellular space to prevent cell swelling (Stutzin et al., 1999). It is not 
yet apparent how exogenous supply of taurine effects this process and it has been speculated 
that high plasma concentrations observed after oral ingestion could supress its normal release 
from the cell (Ishikura, Song-Gyu & Ohmori, 2013). It is also possible that higher plasma 
taurine concentrations could attract fluid to the vascular space, thus contributing to plasma 
volume expansion; however, plasma taurine’s relationship with plasma volume is weaker than 
other osmolytes (Cuisinier et al., 2002). It is unlikely that these osmoregulatory effects would 
alter sweat production but there are possible cardiovascular implications that require further 
investigation in the heat.         
   
The similarity in thermal perception between conditions across the relative stages of the 
protocol was surprising, given the improved thermoregulation in the taurine condition. The 
trend for a lower thermal sensation at the end stages of the trial in the taurine condition 
indicates a possible improved perception, yet this didn’t reach significance. On the other 
hand, RPE was reduced at end stages of the trial in the taurine condition. While the power 
output was fixed between conditions and HR was similar, the increased sweat rate, subsequent 
reduction in body temperatures and post-exercise B[La] appear to have collectively 
contributed to the lower RPE. The lower B[La] in the taurine condition was unanticipated, 
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particularly given the longer time to exhaustion. Whilst changes in B[La] have not typically 
reported in thermoneutral environments following taurine supplementation (Waldron et al., 
2018a; Warnock et al., 2017), it is possible that the reduced thermal strain of the taurine group 
lowered the rate of glycolytic flux (Febbraio, 2001). This finding is also worthy of further 
investigation, as it might indicate an indirect influence of taurine on glycolytic metabolism.   
 
A limitation of this study was the absence of plasma or muscle taurine measurements, which 
would confirm the presence of taurine during the exercising period. However, the timing and 
availability of plasma taurine following oral ingestion has been established using identical 
procedures to those adopted here, albeit at lower doses (1.66 g; Galloway et al., 2008), thus, it 
was assumed that the 50 mg/kg would provide adequate delivery of taurine to exert an 
ergogenic effect.    
 
Conclusion 
This is the first study to examine the effect oral taurine ingestion on thermoregulation during 
cycling in the heat. Compared to placebo, taurine supplementation of 50 mg·kg-1 body mass 
increased time to exhaustion (~ 10%) and local sweating (~ 12.7%), while decreasing RPE 
and core temperature in the later stages of exercise, as well as reducing post-exercise B[La]. 
Therefore, this study also provides the first evidence of taurine’s role in thermoregulatory 
processes. Notably, the profound influence of taurine on sudomotor function was an important 
finding of the current study and indicates a potential central mechanism, as previously 
described in animal models. These findings have implications for short-term preparation 
strategies of individuals exercising in the heat. Based on our findings, a single dose of taurine 
2-h prior to training or competition would provide an ergogenic and thermoregulatory effect. 
Given that this is the first study to report on this topic, future research should attempt to 
corroborate our findings across different populations and investigate the potential explanatory 
mechanisms.       
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List of Figures 
Figure 1. Time to exhaustion at the power output associated with ventilatory threshold fol-
lowing taurine supplementation or placebo (n = 11) in a hot environment (35 °C), (* p < 
0.05). 
 
Figure 2. Core and skin temperature during exercise at the power output associated with 
ventilatory threshold following taurine (black) supplementation or placebo (white) in a hot 
environment (35 °C). (A) Core temperature expressed as a proportion of the exercise trial (* p 
< 0.05), (B) Core temperature in real time, (C) Skin temperature expressed as a proportion of 
the exercise trial (* p < 0.05) and (D) Skin temperature in real time (n = 11). 
 
Figure 3. Sweat rate during exercise at the power output associated with ventilatory threshold 
following taurine (black) supplementation or placebo (white) in a hot environment (35 °C). 
(A) expressed as a proportion of the exercise trial (* p < 0.05) and (B) in real time. (n = 11). 
 
Figure 4. Perceptual measures of (A) effort (RPE), (B) thermal comfort (TC) and (C) thermal 
sensation (TS) during exercise at the power output associated with ventilatory threshold 
following taurine (black) supplementation or placebo (white) (n = 11) in a hot environment 
(35 °C), (* p < 0.05).
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